Acumen Pharmaceuticals OverviewAcumen Pharmaceuticals Net Income
Profitability analysis for ABOS.
Quarterly Net Income
-$20.74M
↑ 27.99% YoY
As of Mar 2026
Annual Net Income (TTM)
-$113.28M
↑ 2.56% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...